Equity in Access Research Grants
The Leukemia & Lymphoma Society
Description
The Leukemia & Lymphoma Society's Equity in Access Research Program offers funding to support research aimed at improving access to cancer clinical trials for underrepresented groups. This program seeks to influence healthcare policy and practice so that all blood cancer patients can receive the best treatment available, regardless of factors like race, ethnicity, disability, sexual orientation, gender identity, socioeconomic status, geography, or language. It encourages collaboration am…
The Leukemia & Lymphoma Society’s (LLS) Equity in Access Research Program aims to build evidence for effective interventions to increase therapeutic cancer clinical trial accrual, focusing on promoting access for patients from underrepresented groups. This funding opportunity supports resear…
Source
Agency
The Leukemia & Lymphoma Society
Key Dates
Opportunity Posted
May 27, 2024
Eligibility
The following categories of applicants are invited to apply:
- Public and State controlled institutions of higher education
- Nonprofits
- Residents of All
Awards & Funding
Award Ceiling
$500,000
Funding Amount
~$500,000
Links
Similar opportunities
- NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12)
National Institutes of Health
- Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings
National Institutes of Health
- Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations
National Institutes of Health
- Addressing Barriers and Facilitators to Cancer Screening and Preventive Services in Populations Experiencing Health Disparities
National Institutes of Health
- Notice of Special Interest (NOSI): Research on Health Disparities
National Institutes of Health